# Pfizer: portfolio, investments and team > Pfizer is a corporate vc based in United States. 84 investments on record, 3 in the last 12 months, latest Jun 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/pfizer (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Pfizer Last cheque observed Jun 2026; 84 cheques on record. Email Deploying now Corporate VC Seed Series A Series B Apps Local Advertising Medical Device Follow Pfizer and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fpfizer) Deploying now **100%** of best year **3** **cheques in 12 months**, 84 on record Since the last cheque **135** days **00** hrs **00** min **00** sec Median round **$51M** Rounds led **4 of 84** Sole investor **9 rounds** Exits **7 from the portfolio** Mostly in **United States, 79%** Pitch Pfizer ## Pfizer highlights - 01 3 cheques in the last 12 months - 02 Mostly Series B and Series A: 69% of its rounds - 03 Sole investor in 9 rounds, median $7.0M - 04 7 exits from the portfolio ## What they do > The page mentions 'Venture Investments' under 'Research and Business Development Partnerships', indicating a corporate venture capital arm. From their own website - **Type:** Corporate VC (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Apps Local Advertising Medical Device - **Based in:** New York, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **84 appearances** - **2026** 3 rounds - **Jun** **[COUR Pharma](https://millionrounds.com/company/cour-pharma)** Series B · US · Lumira Ventures **$50M** With 7 others - **May** **[CellCentric](https://millionrounds.com/company/cellcentric)** Growth · Ventureburn **$220M** With 6 others - **Apr** **[Storm Therapeutics](https://millionrounds.com/company/storm-therapeutics)** Series C · Fast Track Initiative **$56M** With 5 others - **2024** 2 rounds - **Nov** **[TRex Bio](https://millionrounds.com/company/trex-bio)** Series B · US · Avego Management **$84M** With 8 others - **Mar** **[Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics)** Series B · US · Firms' own news pages **$175M** With 15 others - **2019** 9 rounds - **Dec** **[Tripley Therapeutics](https://millionrounds.com/company/tripley-therapeutics)** Series A · US · FinSMEs **$59M** With 1 other - **Dec** **[ImmunOS](https://millionrounds.com/company/immunos)** Series A · CH · FinSMEs **$15M** *Led* - **Dec** **[ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics)** Series B · FR · FinSMEs **$53M** *Led* - **Nov** **[Arkuda](https://millionrounds.com/company/arkuda)** Series A · US · FinSMEs **$44M** *Led* - **May** **[Storm Therapeutics](https://millionrounds.com/company/storm-therapeutics)** Series A · GB · FinSMEs **$18M** With 4 others - **Apr** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series B · US · FinSMEs **$75M** With 13 others - **Apr** **[SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics)** Series B · US · FinSMEs **$125M** With 12 others - **Mar** **[Vivet Therapeutics](https://millionrounds.com/company/vivet-therapeutics)** FR · FinSMEs **$51M** Sole investor - **Feb** **[Gliknik](https://millionrounds.com/company/gliknik)** US · Technical **$15M** Sole investor - **2018** 8 rounds - **Nov** **[Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics)** Series B · US · FinSMEs **$65M** *Led* - **Sept** **[4D Molecular](https://millionrounds.com/company/4d-molecular)** Series B · US · Endpts **$90M** With 9 others - **Aug** **[Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience)** Series A · US · FinSMEs **$31M** With 10 others - **Aug** **[Therachon](https://millionrounds.com/company/therachon)** Series B · CH · FinSMEs **$60M** With 8 others - **Jun** **[Nimbus](https://millionrounds.com/company/nimbus)** US · FinSMEs **$65M** With 6 others - **May** **[Cortexyme](https://millionrounds.com/company/cortexyme)** Series B · US · FinSMEs **$76M** With 10 others - **May** **[Strata](https://millionrounds.com/company/strata)** Series B · US · FinSMEs **$26M** With 5 others - **Apr** **[RefleXion](https://millionrounds.com/company/reflexion)** Series C · US · FinSMEs **$100M** With 6 others - **2017** 9 rounds - **Oct** **[Cydan](https://millionrounds.com/company/cydan)** US · FinSMEs **$34M** With 5 others - **Oct** **[Palleon](https://millionrounds.com/company/palleon)** Series A · US · FinSMEs **$48M** With 4 others - **Sept** **[SpringWorks](https://millionrounds.com/company/springworks)** Series A · US · FinSMEs **$103M** With 4 others - **Jun** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series G · US · FinSMEs **$15M** With 11 others - **Apr** **[Aquinnah](https://millionrounds.com/company/aquinnah)** US · FinSMEs **$10M** With 1 other - **Feb** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series A · US · FinSMEs **$38M** With 4 others - **Feb** **[Rhythm](https://millionrounds.com/company/rhythm)** US · FinSMEs **$41M** With 6 others - **Jan** **[Amra](https://millionrounds.com/company/amra)** SE · FinSMEs **$9.0M** With 3 others - **Jan** **[Molecular Stethoscope](https://millionrounds.com/company/molecular-stethoscope)** Seed · US · FinSMEs **$8.2M** With 2 others - **2016** 2 rounds - **Sept** **[AnTolRx](https://millionrounds.com/company/antolrx)** Series A · US · FinSMEs **$4.0M** Sole investor - **Jun** **[Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic)** Series A · US · Businesswire **$52M** With 1 other - **2015** 7 rounds - **Aug** **[Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals)** Series A · US **$40M** With 7 others - **Jul** **[Autifony Therapeutics](https://millionrounds.com/company/autifony-therapeutics)** Series A · GB **$12M** With 4 others - **Apr** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series F · US **$34M** With 7 others - **Apr** **[Merus](https://millionrounds.com/company/merus)** Series C · NL **$79M** With 10 others - **Mar** **[Nimbus Therapeutics](https://millionrounds.com/company/nimbus-therapeutics)** Series B · US **$43M** With 5 others - **Mar** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Series B · US **$35M** With 4 others - **Jan** **[CytomX Therapeutics](https://millionrounds.com/company/cytomx-therapeutics)** Series C · US **$20M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **23** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **5+** funds on file numbered funds in its name ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[DVS Sciences](https://millionrounds.com/company/dvs-sciences)** Bought by Fluidigm **$208M** Jan 2014 **[Five Prime Therapeutics](https://millionrounds.com/company/five-prime-therapeutics)** Listed **Undisclosed** Jul 2013 **[SuperDimension](https://millionrounds.com/company/superdimension)** Bought by [Covidien](https://millionrounds.com/fund/covidien) **$300M** Mar 2012 **[ICAgen](https://millionrounds.com/company/icagen)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **$56M** Oct 2011 **[Avid Radiopharmaceuticals](https://millionrounds.com/company/avid-radiopharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **$800M** Nov 2010 **[HandyLab](https://millionrounds.com/company/handylab)** Bought by Becton Dickinson **$275M** Oct 2009 **[Coley Pharmaceutical Group](https://millionrounds.com/company/coley-pharmaceutical-group)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Nov 2007 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **Allergan** **$160B** Nov 2015 **Hospira** **$15B** Feb 2015 **[Redvax](https://millionrounds.com/company/redvax)** **Undisclosed** Jan 2015 **Baxter International** **$635M** Jul 2014 **[InnoPharma](https://millionrounds.com/company/innopharma)** **$225M** Jul 2014 **[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** **Undisclosed** Oct 2012 **[ICAgen](https://millionrounds.com/company/icagen)** **$56M** Oct 2011 **King Pharmaceuticals** **$3.6B** Oct 2010 **[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** **Undisclosed** Sept 2010 **Wyeth Pharmaceuticals** **$68B** Jan 2009 **[Serenex](https://millionrounds.com/company/serenex)** **Undisclosed** Mar 2008 **[Encysive Pharmaceuticals](https://millionrounds.com/company/encysive-pharmaceuticals)** **$195M** Feb 2008 ## The cheque Seed Series A Series B Median round joined **$51M** the round, not its cheque Alone, median **$7.0M** Led 4 of 84 rounds **5%** - **Sole investor:** 9 rounds - **Last cheque:** Jun 2026 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B said *24* - Series A said *24* - Series C *10* - Venture *7* - Series D *5* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 13 - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 7 - [OrbiMed](https://millionrounds.com/fund/orbimed) 7 - [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 6 - [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 6 - [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) 6 **Pitching Pfizer?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Pfizer. A count of rooms they were both in, not a relationship either has claimed. [**New Enterprise Associates** VC firm **13** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Alexandria Real Estate Equities** VC firm **7** rounds together](https://millionrounds.com/fund/alexandria)[**OrbiMed** Private equity **7** rounds together](https://millionrounds.com/fund/orbimed)[**Novartis Venture Fund** Corporate VC **6** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Roche Venture Fund** Corporate VC **6** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**Sofinnova Investments** VC firm **6** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**Atlas Venture** VC firm **5** rounds together](https://millionrounds.com/fund/atlas-venture)[**Osage University Partners** VC firm **5** rounds together](https://millionrounds.com/fund/osage-university-partners)[**SR One** Corporate VC **5** rounds together](https://millionrounds.com/fund/sr-one)[**Third Rock Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/third-rock-ventures)[**Bay City Capital** VC firm **4** rounds together](https://millionrounds.com/fund/bay-city-capital)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **4** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) ## Recently backed The latest companies Pfizer put money into. [**COUR Pharma** $50M · Jun 2026](https://millionrounds.com/company/cour-pharma)[**CellCentric** $220M · May 2026](https://millionrounds.com/company/cellcentric)[**Storm Therapeutics** $56M · Apr 2026](https://millionrounds.com/company/storm-therapeutics)[**ImCheck Therapeutics** $53M · Dec 2019](https://millionrounds.com/company/imcheck-therapeutics)[**Arrakis Therapeutics** $75M · Apr 2019](https://millionrounds.com/company/arrakis-therapeutics)[**SpringWorks Therapeutics** $125M · Apr 2019](https://millionrounds.com/company/springworks-therapeutics) ## Quick answers about Pfizer ### What does Pfizer invest in? Pfizer invests most often at Series B and Series A (69% of the rounds on record), in sectors such as Apps, Local Advertising and Medical Device. ### How active is Pfizer? 84 investments on record, 3 of them in the last 12 months, and it led 4. The most recent was in Jun 2026. ### What has Pfizer invested in recently? Its most recent investments on record: COUR Pharma (Series B, Jun 2026), CellCentric (Growth, May 2026) and Storm Therapeutics (Series C, Apr 2026). ### How big are Pfizer's cheques? The median round it joins is $51M. ### Does Pfizer lead rounds? Sometimes: it led 4 of its 84 investments on record (5%). ### Where does Pfizer invest? Most of the companies it backs are in the United States (79%), Switzerland (5%) and France (5%). ### Is Pfizer investing now? Yes: it is actively investing, with 3 investments in the last 12 months. ### Who does Pfizer invest alongside? Most often New Enterprise Associates (13 rounds together), Alexandria Real Estate Equities (7 rounds together) and OrbiMed (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=pfizer) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=pfizer)